Global market valuation was derived through revenue mapping and volume analysis across edible CBD categories. The methodology included:
Identification of 55+ key manufacturers and white-label producers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across vegan, non-vegan, low-sugar, and high-potency CBD gummy categories, including segmentation by CBD extract type (full-spectrum, broad-spectrum, isolate) and flavor profiles (fruity, mint, chocolate, sour, mixed berry)
Analysis of reported and modeled annual revenues specific to CBD-infused edible portfolios, including direct-to-consumer and B2B wholesale channels
Coverage of manufacturers representing 65-70% of global market share in 2024
Extrapolation using bottom-up (unit volume × average selling price by country/region) and top-down (manufacturer revenue validation and trade association data) approaches to derive segment-specific valuations for pain relief, anxiety relief, sleep aid, anti-inflammatory, and general wellness applications